Mongolian medicine for curing lung interstitial substance fibrosis

Abstract

The invention relates to a drug, in particular to a Mongolian drug for curing the pulmonary interstitial fibrosis. The Mongolian drug is prepared by the following bulk drugs calculated according to the amounts by weight: 40 to 80 parts of leaf of Chinese ilex, 30 to 50 parts of red sange root, 30 to 50 parts of beach silvertop root, 10 to 30 parts of seabuckthorn fruit, 10 to 30 parts of bitter apricot kernel, 10 to 30 parts of licorice root and 5 to 20 parts of tabasheer. Because the experimental dosage type adopts a capsule, the drug is called compound holly capsule. A plurality of clinical experiments are verified that the compound holly capsule has the functions of clearing Badegan pathogenic heat, reducing phlegm and resolving masses, relieving asthma and activating the channels; the drug has unique therapeutic effect to the interstitial pulmonary fibrosis, and simultaneously has good therapeutic effects on the respiratory diseases, such as the wintercough, the bronchitis, the emphysema and the asthma.

Description

Technical field [0001] The invention relates to a medicine, namely a Mongolian medicine for treating pulmonary interstitial fibrosis. Background technique [0002] Idiopathic pulmonary fibrosis (IPF) refers to a diffuse inflammatory disease of the lower respiratory tract of unknown etiology. The pathogenesis of the disease is mostly inflammation invading the alveolar wall and adjacent alveolar spaces, resulting in thickening of alveolar septa and pulmonary fibrosis. Alveolar epithelial cells and capillary endothelial cells, as well as small airways and small blood vessels, may also be affected. Its clinical features include progressive dyspnea, Velcro rales, and progressive hypoxemia. Impaired lung function is mainly restricted ventilatory dysfunction and diffusion dysfunction. The prevalence rate is about 2-5 / 100,000, and the age of onset is mostly 40-50 years old. Most of the disease courses are chronic, and those with sudden onset are rare. There is no accurate epidem...

AI Technical Summary

Problems solved by technology

Western medicine mainly uses glucocorticoids and immunosuppressants for this disease, and the treatment effect is very limited, and many complications will follow, making the treatment more complicated

There is no record of this disease in the ancient literature of traditional Chinese medicine. In recent years, some research reports have referred to the disease as "shortness of breath", "cough", "lung atrophy", "lung distention" and "lung impediment", etc. No drug with definite curative effect has been reported